THERAVANCE BIOPHARMA INC's ticker is TBPH and the CUSIP is G8807B106. A total of 116 filers reported holding THERAVANCE BIOPHARMA INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $12,696,344 | -17.0% | 1,471,187 | -0.4% | 0.00% | 0.0% |
| Q2 2023 | $15,289,931 | -0.1% | 1,477,288 | +4.7% | 0.00% | 0.0% |
| Q1 2023 | $15,309,437 | -52.4% | 1,411,008 | -50.8% | 0.00% | 0.0% |
| Q4 2022 | $32,154,702 | +113.6% | 2,865,838 | +93.0% | 0.00% | 0.0% |
| Q3 2022 | $15,055,000 | +11.1% | 1,484,759 | -0.7% | 0.00% | 0.0% |
| Q2 2022 | $13,545,000 | -8.1% | 1,495,046 | -3.0% | 0.00% | 0.0% |
| Q1 2022 | $14,737,000 | -1.9% | 1,541,533 | +13.3% | 0.00% | 0.0% |
| Q4 2021 | $15,030,000 | +48.0% | 1,360,202 | -0.9% | 0.00% | 0.0% |
| Q3 2021 | $10,155,000 | -44.3% | 1,372,247 | +9.3% | 0.00% | 0.0% |
| Q2 2021 | $18,238,000 | -22.5% | 1,256,058 | +9.0% | 0.00% | 0.0% |
| Q1 2021 | $23,525,000 | +26.2% | 1,152,619 | +9.8% | 0.00% | 0.0% |
| Q4 2020 | $18,647,000 | +15.5% | 1,049,345 | -3.9% | 0.00% | 0.0% |
| Q3 2020 | $16,141,000 | -30.5% | 1,091,684 | -1.3% | 0.00% | -50.0% |
| Q2 2020 | $23,211,000 | -4.8% | 1,105,831 | +4.8% | 0.00% | 0.0% |
| Q1 2020 | $24,387,000 | -1.8% | 1,055,268 | +10.0% | 0.00% | 0.0% |
| Q4 2019 | $24,843,000 | +34.6% | 959,564 | +1.3% | 0.00% | +100.0% |
| Q3 2019 | $18,460,000 | +20.4% | 947,616 | +1.0% | 0.00% | 0.0% |
| Q2 2019 | $15,326,000 | -25.2% | 938,504 | +3.8% | 0.00% | -50.0% |
| Q1 2019 | $20,488,000 | -9.2% | 903,754 | +2.5% | 0.00% | 0.0% |
| Q4 2018 | $22,561,000 | -21.9% | 881,646 | -0.2% | 0.00% | 0.0% |
| Q3 2018 | $28,871,000 | +45.1% | 883,798 | +0.7% | 0.00% | 0.0% |
| Q2 2018 | $19,901,000 | -4.7% | 877,393 | +1.9% | 0.00% | 0.0% |
| Q1 2018 | $20,891,000 | -15.2% | 861,451 | -2.5% | 0.00% | 0.0% |
| Q4 2017 | $24,631,000 | -21.3% | 883,096 | -3.4% | 0.00% | -33.3% |
| Q3 2017 | $31,289,000 | -11.7% | 913,836 | +2.7% | 0.00% | 0.0% |
| Q2 2017 | $35,443,000 | +10.6% | 889,682 | +2.2% | 0.00% | 0.0% |
| Q1 2017 | $32,042,000 | +18.1% | 870,254 | +2.3% | 0.00% | 0.0% |
| Q4 2016 | $27,136,000 | +4.1% | 851,024 | +18.3% | 0.00% | 0.0% |
| Q3 2016 | $26,070,000 | +61.9% | 719,378 | +1.4% | 0.00% | +50.0% |
| Q2 2016 | $16,099,000 | +57.2% | 709,571 | +30.4% | 0.00% | +100.0% |
| Q1 2016 | $10,238,000 | +18.2% | 544,207 | +2.9% | 0.00% | 0.0% |
| Q4 2015 | $8,660,000 | +0.6% | 528,633 | -32.5% | 0.00% | 0.0% |
| Q3 2015 | $8,607,000 | -23.4% | 782,864 | -9.3% | 0.00% | 0.0% |
| Q2 2015 | $11,236,000 | -35.5% | 863,278 | -14.1% | 0.00% | -50.0% |
| Q1 2015 | $17,433,000 | +21.7% | 1,004,909 | +4.7% | 0.00% | +100.0% |
| Q4 2014 | $14,322,000 | -44.1% | 960,160 | -13.7% | 0.00% | -66.7% |
| Q3 2014 | $25,637,000 | +35.1% | 1,112,037 | +86.9% | 0.00% | +50.0% |
| Q2 2014 | $18,970,000 | – | 594,858 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Madison Avenue Partners, LP | 7,012,226 | $60,515,510 | 8.59% |
| Irenic Capital Management LP | 2,760,948 | $23,826,981 | 6.76% |
| Newtyn Management, LLC | 1,841,560 | $15,892,663 | 3.92% |
| Weiss Asset Management LP | 7,457,060 | $64,354,428 | 3.81% |
| Park West Asset Management LLC | 1,983,251 | $17,115,456 | 1.57% |
| Baupost Group | 7,419,226 | $64,028 | 1.23% |
| Oasis Management Co Ltd. | 953,254 | $8,226,582 | 0.36% |
| Chescapmanager LLC | 287,333 | $2,479,684 | 0.32% |
| GSA CAPITAL PARTNERS LLP | 325,985 | $2,813 | 0.24% |
| Virtus ETF Advisers LLC | 29,232 | $252,272 | 0.15% |